Benitec Biopharma Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Benitec Biopharma stock has a consensus rating of "Strong Buy" and an average price target of $24.33. The average 1-year stock price forecast is 130.73% higher than the current stock price, while the lowest is $17 (+61.21%) and the highest is $32 (+203.46%).

Price Target: $24.33 (+130.73%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$17	$24.33	$24.5	$32
Change	+61.21%	+130.73%	+132.34%	+203.46%

Analyst Ratings

The average analyst rating for Benitec Biopharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	6	6	6	6	6	6
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ram Selvaraju H.C. Wainwright	H.C. Wainwright	Buy Reiterates $32	Buy	Reiterates	$32	+203.46%	May 26, 2026
Unknown Analyst Leerink Partners No rating	Leerink Partners	Buy Reiterates $18	Buy	Reiterates	$18	+70.70%	May 15, 2026
Ritu Baral TD Cowen	TD Cowen	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 15, 2026
Cory Kasimov Evercore ISI	Evercore ISI	Buy Initiates $25	Buy	Initiates	$25	+137.08%	May 12, 2026

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

21.86M

EPS This Year

-10.37

EPS Next Year

6.29

from -10.37

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026
Revenue	59.00K	73.00K	75.00K	-	-	-
Operating Income	-13.60M	-17.85M	-19.08M	-22.49M	-41.77M	-50.70M
Net Income	-13.88M	-18.21M	-19.56M	-21.75M	-37.92M	-47.19M
EPS	-	-	-	-	-	-10.37
Free Cash Flow	-7.28M	-8.72M	-10.19M	-11.68M	-11.46M	-22.78M
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-10.37
Low	-

EPS Growth

EPS Growth	2027	2028
High	-
Avg	-
Low	-